Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Beukers

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Biochemical Pharmacology|August 15, 1990
Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amilorideA Garritsen, A P Ijzerman, M W Beukers, et al.
European Journal of Pharmacology|January 1, 1994
Nucleoside transport inhibition and platelet aggregation in human blood: R75231 and its enantiomers, draflazine and R88016M W Beukers, C J Kerkhof, A P IJzerman, et al.
Endocrinology|February 1, 1991
[Leu27] insulin-like growth factor II is highly selective for the type-II IGF receptor in binding, cross-linking and thymidine incorporation experimentsM W Beukers, Y Oh, H Zhang, et al.
Neurochemistry International|February 11, 1992
The mode of interaction of amiloride and some of its analogues with the adenosine A1 receptorA Garritsen, M W Beukers, A P IJzerman, et al.
Biochemical Pharmacology|August 15, 1990
Interaction of amiloride and its analogues with adenosine A1 receptors in calf brainA Garritsen, A P Ijzerman, M W Beukers, et al.
British Journal of Pharmacology|December 1, 1994
Pharmacological analysis of ecto-ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligandsB E Crack, M W Beukers, K C McKechnie, et al.
Biochemical Pharmacology|November 25, 1998
Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptorsA Dalpiaz, A Townsend-Nicholson, M W Beukers, et al.
Molecular Pharmacology|November 28, 2000
Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosineM W Beukers, H den Dulk, E W van Tilburg, et al.
British Journal of Pharmacology|February 12, 1998
Heterologous expression of rat epitope-tagged histamine H2 receptors in insect Sf9 cellsM W Beukers, C H Klaassen, W J De Grip, et al.
The Biochemical Journal|August 15, 1991
Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II moleculeY Oh, M W Beukers, H M Pham, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biochemical Pharmacology|August 15, 1990
Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amilorideA Garritsen, A P Ijzerman, M W Beukers, et al.
European Journal of Pharmacology|January 1, 1994
Nucleoside transport inhibition and platelet aggregation in human blood: R75231 and its enantiomers, draflazine and R88016M W Beukers, C J Kerkhof, A P IJzerman, et al.
Endocrinology|February 1, 1991
[Leu27] insulin-like growth factor II is highly selective for the type-II IGF receptor in binding, cross-linking and thymidine incorporation experimentsM W Beukers, Y Oh, H Zhang, et al.
Neurochemistry International|February 11, 1992
The mode of interaction of amiloride and some of its analogues with the adenosine A1 receptorA Garritsen, M W Beukers, A P IJzerman, et al.
Biochemical Pharmacology|August 15, 1990
Interaction of amiloride and its analogues with adenosine A1 receptors in calf brainA Garritsen, A P Ijzerman, M W Beukers, et al.
British Journal of Pharmacology|December 1, 1994
Pharmacological analysis of ecto-ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligandsB E Crack, M W Beukers, K C McKechnie, et al.
Biochemical Pharmacology|November 25, 1998
Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptorsA Dalpiaz, A Townsend-Nicholson, M W Beukers, et al.
Molecular Pharmacology|November 28, 2000
Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosineM W Beukers, H den Dulk, E W van Tilburg, et al.
British Journal of Pharmacology|February 12, 1998
Heterologous expression of rat epitope-tagged histamine H2 receptors in insect Sf9 cellsM W Beukers, C H Klaassen, W J De Grip, et al.
The Biochemical Journal|August 15, 1991
Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II moleculeY Oh, M W Beukers, H M Pham, et al.
Pageof 2